Sharp Therapeutics Corp. Announces Results from Annual Meeting of Shareholders
Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - July 21, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) ("Sharp" or the "Company"), a pre-clinical biotechnology company developing small molecule therapies to treat genetic diseases, is pleased to announce the voting results from its annual general meeting of shareholders held on July 21, 2026 (the "Meeting").All nominees set forth in the Company's amended and restated management information circular dated June 17, 2026 (the...
Free plan · Plus CA$29 or Pro CA$99/month


